Macquarie Group’s AnaptysBio ANAB Stock Holding History

Macquarie Group’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-93,732	Closed	-$2.87M	–	883
2025 Q3	$2.87M	Hold	93,732	–	–	﹤0.01%	1076
2025 Q2	$2.08M	Hold	93,732	–	–	﹤0.01%	1217
2025 Q1	$1.74M	Hold	93,732	–	–	﹤0.01%	1264
2024 Q4	$1.24M	Hold	93,732	–	–	﹤0.01%	1312
2024 Q3	$3.14M	Hold	93,732	–	–	﹤0.01%	1090
2024 Q2	$2.35M	Hold	93,732	–	–	﹤0.01%	1182
2024 Q1	$2.11M	Hold	93,732	–	–	﹤0.01%	1206
2023 Q4	$2.01M	Hold	93,732	–	–	﹤0.01%	1222
2023 Q3	$1.68M	Hold	93,732	–	–	﹤0.01%	1213
2023 Q2	$1.91M	Hold	93,732	–	–	﹤0.01%	1200
2023 Q1	$2.04M	Hold	93,732	–	–	﹤0.01%	1164
2022 Q4	$2.9M	Hold	93,732	–	–	﹤0.01%	1100
2022 Q3	$2.4M	Sell	93,732 -472	-0.5%	-$11.1K	﹤0.01%	1166
2022 Q2	$1.91M	Hold	94,204	–	–	﹤0.01%	1313
2022 Q1	$2.33M	Hold	94,204	–	–	﹤0.01%	1327
2021 Q4	$3.27M	Hold	94,204	–	–	﹤0.01%	1232
2021 Q3	$2.56M	Hold	94,204	–	–	﹤0.01%	1299
2021 Q2	$2.44M	Hold	94,204	–	–	﹤0.01%	1352
2021 Q1	$2.03M	Sell	94,204 -224	-0.2%	-$5.65K	﹤0.01%	1205
2020 Q4	$2.03M	Hold	94,428	–	–	﹤0.01%	1096
2020 Q3	$1.39M	Buy	94,428 +93,732	+13,467%	+$1.69M	﹤0.01%	1151
2020 Q2	$16K	Buy	+696	New	+$12.7K	﹤0.01%	2216
2018 Q3	–	Sell	-400	Closed	-$28K	–	2149
2018 Q2	$28K	Buy	+400	New	+$33.6K	﹤0.01%	2026

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Macquarie Group's ANAB Position: Q4 2025 in Review

Macquarie Group sold out of AnaptysBio (ANAB) in Q4 2025, closing a stake of 93,732 shares — an estimated $2.87M sold.

Macquarie Group first reported a position in ANAB in Q2 2018 and held it in 23 quarters. The position peaked at $3.27M in Q4 2021. 179 funds tracked by Wall St. Rank hold ANAB as of Q4 2025.

Macquarie Group reported no remaining AnaptysBio position as of Q4 2025 after selling out during the quarter.
Macquarie Group sold 93,732 AnaptysBio shares in Q4 2025, an estimated $2.87M.
Macquarie Group first reported a position in AnaptysBio in Q2 2018 and held it in 23 quarters.
Macquarie Group's AnaptysBio position peaked at $3.27M in Q4 2021.
179 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.